EC Consumer Health

Deal Dive: Caraway shows what else digital health can do

Caraway, which looks to provide supplemental telehealth services to Gen Z, has raised a $16.75 million Series A round.

How Mindbloom’s CEO sees the future of psychedelic mental health

“What was something amazing that happened to you this weekend,” Mindbloom’s CEO Dylan Beynon asked me, less than 30 seconds into our call. His bright eyes and relaxed demeanor radiated a deep pe

Mapping out the future of AR, ThirdEye is taking on Google and Microsoft in real-life scenarios

ThirdEye's second-gen X2 MR glasses can be used for various sectors, including health care and manufacturing.

Despite 2022’s headwinds, women’s health startups did better than ever before

TechCrunch conducted a vibe check to see where this sector stands, and found a prevailing sense of guarded optimism.

Predictions for the longevity industry in 2023

This year will shift the conversation from "life span" to "health span" — how we live healthier for longer.

Digital health startups can incorporate clinical expertise into business models — here’s how

Digital health startups should have clinical experts as part of its leadership to ensure care is always based on the patient's medical needs.

Pitch Deck Teardown: MedCrypt’s $25M Series B deck

MedCrypt shared with us the deck it used to raise a $25 million Series B.

Pitch Deck Teardown: Rootine’s $10M Series A deck

The slide deck bespoke vitamin startup Rootine used to raise a $10 million Series A is a master class. Let's check out some of the highlights.

Holmes’ sentencing sends a clear message that the startup ecosystem must be built on good faith

The startup ecosystem is built on trust, and the Holmes verdict on Friday sent a clear message that there are consequences for breaking it.

I will defend the $700M fizzy water

Liquid Death is more than simply bougie water. It comes with built-in liquidity, ensuring that its investors won't be parched on the deal.

How gender-affirming healthcare startups are navigating legal miasma

Better late than never: It’s a critical time for the startup and venture communities to support trans founders.

FDA decision to allow over-the-counter hearing loss technology will be a catalyst for innovation

The FDA on Monday announced that hearing aids and other hearing technology can now be sold over the counter, ending a system that mandated a prescription.

5 investors explain why longevity tech is a long-term play

It’s becoming clear that longevity as a theme has resonated with investors, though it appears it will be some time before more generalist investors take interest.

How digital health startups are navigating the post-Roe legal landscape

As state laws shift and abortion bans go into effect across the United States, companies are still trying to find ways to provide care while reimagining what healthcare should include.

Pitch Deck Teardown: Alto Pharmacy’s $200M Series E deck

Today we tear down the pitch deck that landed Alto Pharmacy a $200 million Series E.

3 views on Amazon’s $3.9B acquisition of One Medical

After it was rumored to be in play earlier this month, it shouldn’t come as a huge surprise that One Medical has found a new home. After a torrid public offering, the value of the American consumer

What does Amazon get for the $3.9B it is paying for One Medical?

This morning, let's peek at One Medical's latest financial results to both understand the deal and what Amazon is really buying.

Can Medicare save the insurtech market?

How is it possible that an over $5 trillion industry cannot seem to attract capital? Have investors picked the wrong business models, or are there pockets within insurtech that have been ignored?

Digital health unicorns need a checkup

Digital health unicorns Ro, Cerebral, Calibrate and Forward's layoff stories share a through line that reveals the unique challenges of being a venture-backed healthcare business.

After Roe’s reversal, founders of women’s health startups prepare for battle

TechCrunch conducted a vibe check with the women founders taking themselves and their companies to the front lines of the fight for abortion.
Load More